Precision cancer tests encompass imaging and in vitro diagnostic (IVD) products and procedures that directly detect malignancies in patient samples or in the patients themselves.

Market Analysis and Insights: Global Precision Cancer Diagnostic Tests Market
The global Precision Cancer Diagnostic Tests market size is projected to reach US$ 9770.4 million by 2027, from US$ 4148.6 million in 2020, at a CAGR of 12.5% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Precision Cancer Diagnostic Tests market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Precision Cancer Diagnostic Tests market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Precision Cancer Diagnostic Tests market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Precision Cancer Diagnostic Tests market.

Global Precision Cancer Diagnostic Tests Scope and Market Size
Precision Cancer Diagnostic Tests market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Precision Cancer Diagnostic Tests market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Imaging
Molecular
Histology/Cytology
Tumor Marker Immunoassays
POC Colon Cancer Tests

Segment by Application
Hospital
Clinic
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott Laboratories
Agilent Technologies
Becton Dickinson and Company
Bio-Rad Laboratories
Biocartis N.V.
Biocept
bioMerieux SA
Canon Medical Systems Corporation
Cynvenio Biosystems
Danaher Corporation
Epigenomics AG
Exosome Diagnostics
Foundation Medicine
General Electric Company
Genomic Health
Hologic
Illumina
Menarini Silicon Biosystems SpA
Myriad Genetics
NanoString Technologies
Ortho Clinical Diagnostics
QIAGEN N.V.
Randox Laboratories Ltd.
Roche Holding AG
Royal Philips N.V.
Siemens AG
Thermo Fisher Scientific
Vela Diagnostics